Shubhrat Maheshwari

Mr. Shubhrat Maheshwari


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2024 in Ageing Research Reviews
Verified
Journal Article
Closed access
SMShubhrat Maheshwari
Shubhrat Maheshwari
ASADITYA SINGH
ADITYA SINGH
VAVaseem Ahmad Ansari
Vaseem Ahmad Ansari
TMTarique Mahmood
Tarique Mahmood
RWRufaida Wasim
Rufaida Wasim
AVAmita Verma
Amita Verma

31 May 2023 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
SMShubhrat Maheshwari
Shubhrat Maheshwari
The involvements of iron metabolism, lipid peroxidation, and oxidative stress in Alzheimer's disease (AD) development have recently received a lot of attention. We also observe that these pathogenic occurrences play a key role in regulating ferroptosis, a unique regulatory cell death that is iron-dependent, oxidative, and non-apoptotic. Iron is a crucial component that makes up a subunit of the oxidase responsible for lipid peroxidation. A family of non-heme iron enzymes known as lipoxygenases (LOXs) can cause ferroptosis by oxidising polyunsaturated fatty acids in cellular membranes (PUFAs). Toxic lipid hydroperoxides are produced in large part by the iron in LOX active sites. Deferoxamine and deferiprone, two iron chelators, could also treat ferroptosis by eliminating the crucial catalytic iron from LOXs. Phospholipids containing polyunsaturated fatty acids are the main substrates of lipid peroxidation in ferroptosis, which is favourably controlled by enzymes like ACSL4, LPCAT3, ALOXs, or POR. Selective stimulation of autophagic degradation pathways leads to an increase in iron accumulation and lipid peroxidation, which promotes ferroptosis. We highlighted recent advancements in our understanding of ferroptosis signaling routes in this study. One form of regulated necrotic cell death known as ferroptosis has been linked to a number of diseases, including cancer, neurological disorders, and ischemia/reperfusion injury. Cerebrospinal fluid (CSF) ferritin may be a good indicator of the amount of iron in the brain because it is the main protein that stores iron. Received: 04 April 2023 Accepted after revision: 21 April 2023 Article published online: 31 May 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

16 July 2025 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
SMShubhrat Maheshwari
Shubhrat Maheshwari
ASADITYA SINGH
ADITYA SINGH
AVAmita Verma
Amita Verma
MSMohammad Shariq
Mohammad Shariq
JAJuber Akhtar
Juber Akhtar
Bhupendra G PrajapatiBhupendra G Prajapati
Bhupendra G Prajapati

20 March 2023 in Drug Research
Verified
Journal Article
Closed access
PDF file
SMShubhrat Maheshwari
Shubhrat Maheshwari
Neurofibrillary tangles and plaques containing tau serve as the biological markers for Alzheimer disease (AD) and pathogenesis is widely believed to be driven by the production and deposition of the β-amyloid peptide (Aβ). The β-amyloid peptide (Aβ) that results from the modification of the amyloid precursor protein (APP) by builds up as amyloid deposits in neuronal cells. Thus, a protein misfolding process is involved in the production of amyloid. In a native, aqueous buffer, amyloid fibrils are usually exceedingly stable and nearly insoluble. Although amyloid is essentially a foreign substance made of self-proteins, the immune system has difficulty identifying and eliminating it as such for unknown reasons. While the amyloidal deposit may have a direct role in the disease mechanism in some disease states involving amyloidal deposition, this is not always the case. Current research has shown that PS1 (presenilin 1) and BACE (beta-site APP-cleaving enzyme) have – and -secretase activity that increases β-amyloid peptide (Aβ). Wealth of data has shown that oxidative stress and AD are closely connected that causes the death of neuronal cells by producing reactive oxygen species (ROS). Additionally, it has been demonstrated that advanced glycation end products (AGEs) and β-amyloidal peptide (Aβ) together increase neurotoxicity. The objective of this review is to compile the most recent and intriguing data of AGEs and receptor for advanced glycation end products (RAGE) pathways which are responsible for AD.

2 February 2024 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
SMShubhrat Maheshwari
Shubhrat Maheshwari
ASAditya Singh
Aditya Singh
AVAmita Verma
Amita Verma
Reduced bone mass and degeneration of the microarchitecture of bone tissue are the hallmarks of osteoporosis, a bone metabolic disease that increases skeletal fragility and fracture susceptibility. Osteoporosis is primarily caused by unbalanced bone remodeling, in which bone synthesis is outpaced by bone resorption caused by osteoclasts. Along with the bone-building vitamins calcium and vitamin D, typical medications for treating osteoporosis include bisphosphonates and calcitonin. The present therapies effectively stop osteoclast activation that is too high, however they come with varying degrees of negative effects. Numerous factors can contribute to osteoporosis, which is characterized by a loss of bone mass and density due to the deterioration of the bone’s microstructure, which makes the bone more fragile. As a result, it is a systemic bone condition that makes patients more likely to fracture. Interest in the function of ferroptosis in the pathophysiology of osteoporosis is developing. In this review, we go through the shape of the cell, the fundamental mechanisms of ferroptosis, the relationship between osteoclasts and osteoblasts, the association between ferroptosis and diabetic osteoporosis, steroid-induced osteoporosis, and the relationship between ferroptosis and postmenopausal osteoporosis. The functions of ferroptosis and osteoporosis in cellular function, signaling cascades, pharmacological inhibition, and gene silencing have been better understood thanks to recent advances in biomedical research.

1 February 2024 in Intelligent Pharmacy
Verified
Journal Article
Open access
SMShubhrat Maheshwari
Shubhrat Maheshwari
Background: Silver nanoparticles (AgNPs) have gained significant attention in recent years due to their unique physicochemical properties and potential applications in various fields, including medicine, catalysis, and environmental remediation. These nanoparticles possess antimicrobial, anti-inflammatory, and wound-healing properties, making them particularly promising for biomedical applications. The drug Woodfordia fruticosa (Wf) has been traditionally used in folk medicine for its therapeutic properties, such as wound healing, antimicrobial, anti-inflammatory, and antioxidant effects. Objective: The objective of this study was to develop and optimise the synthesis of silver nanoparticles using flower extracts of Woodfordia fruticosa through the distillation extraction method. By employing this technique, the research aimed to successfully create silver nanoparticles from Woodfordia fruticosa gel for the treatment of wounds. Methods: WF flower extracts were prepared by drying the flowers for 14 days and crushing them into a fine powder. The powdered flowers were then sieved through 80-inch sievesThe extracted material was stored at 4 °C for further processing. In parallel, a 1 mM silver nitrate solution was prepared by dissolving 16.99 mg of silver nitrate in 100 ml of distilled water. The flower extract and silver nitrate solution were then utilised for the synthesis of silver nanoparticles. The characterization of the synthesised silver nanoparticles was conducted using various techniques, including zeta potential analysis and electron microscopy. These techniques were employed to assess the physicochemical properties, stability, and morphology of the silver nanoparticles. After gel preparation, in vivo wound healing activity was performed. Result: The synthesis of AgNPs using WF flower extracts and silver nitrate solution resulted in the successful formation of nanoparticles. The characterization of the synthesised AgNPs was carried out using various techniques. The zeta potential was found to be −0.283 mV, which indicated their stability, and the PDI value was found to be 0.533. These values indicated a stable dispersion of the synthesised AgNPs. Scanning electron microscopy (SEM) showed that nanoparticles have a spherical shape in the range of 5 nm. Conclusion: In conclusion, this study successfully developed silver nanoparticles using flower extracts. The developed gel shows that it has wound-healing properties.